Alternatives to Juvenescence Ltd.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Biotechnology company focused on developing therapies to extend human healthspan and reverse aging.

Leveraging the adaptive immune system to diagnose and treat disease.

BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.

A global oncology company developing and commercializing innovative cancer treatments.

Biotechnology company developing novel therapeutics to promote healthy longevity by understanding aging pathways.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.